Related Experiment Video
Updated: Jun 20, 2025
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Genetic variants of dectin-1 and their antifungal immunity impact in hematologic malignancies: A comprehensive
Mojtaba Aghaei1, Reyhane Khademi2, Mohammad Ali Jalali Far2
1Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Background:
Fungal infections pose a significant threat to individuals with hematologic malignancies due to compromised immune systems. Dectin-1, a pivotal pattern recognition receptor, plays a central role in antifungal immune responses. Understanding its genetic variants' impact is crucial for advancing personalized therapeutic approaches.
Methods:
Employing systematic review methods, studies were meticulously selected and assessed for relevance. Data extraction encompassed Dectin-1 genetic variants, antifungal immune responses, and disease outcomes.
Results:
Findings unveiled a complex relationship between Dectin-1 genetic variants and antifungal immunity in hematologic malignancies. Variable associations emerged, influencing susceptibility to fungal infections and disease prognosis. Moreover, implications for treatment outcomes were explored, suggesting potential avenues for tailored interventions.
Conclusions:
This systematic review underscores the need for further investigation into the precise influence of Dectin-1 genetic variants on antifungal immunity and disease progression in hematologic malignancies. Insights gained could pave the way for personalized therapeutic strategies, optimizing infection prevention and malignancy management. By delving into the intricate connections between genetic nuances, immune responses, and clinical trajectories, this review contributes to the ongoing discourse surrounding hematologic malignancies, fungal infections, and their multifaceted interplay.
Insights
Genetic variants in Dectin-1 influence antifungal immunity and outcomes in patients with hematologic malignancies. Further research is needed for personalized therapies to combat fungal infections.
Area of Science:
- Immunology
- Genetics
- Hematology
Background:
- Hematologic malignancies compromise immune systems, increasing susceptibility to fungal infections.
- Dectin-1, a key pattern recognition receptor, is vital for antifungal immune responses.
- Understanding Dectin-1 genetic variants is essential for personalized medicine in oncology.
Approach:
- A systematic review methodology was employed.
- Studies were selected and assessed for relevance to Dectin-1 genetic variants, immune responses, and clinical outcomes.
- Data extraction focused on the interplay between these factors.
Key Points:
- Dectin-1 genetic variants exhibit a complex association with antifungal immunity in hematologic malignancy patients.
- These variants influence susceptibility to fungal infections and impact disease prognosis.
- Potential links to treatment outcomes suggest avenues for tailored therapeutic interventions.
Conclusions:
- Further research is required to elucidate the exact role of Dectin-1 genetic variants in antifungal immunity and disease progression.
- Personalized therapeutic strategies may be developed to optimize infection prevention and malignancy management.
- This review highlights the intricate relationship between genetic factors, immune function, and clinical outcomes in hematologic malignancies.
